Patent · US Active

Naphthyridines as inhibitors of HPK1

US10407424B2 · kind B2 · utility

3Cited by
0References
72Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2018
Grant dateSep 10, 2019
Priority date—
Expiry dateMar 30, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.